Business Description
Poolbeg Pharma PLC
ISIN : GB00BKPG7Z60
Share Class Description:
LSE:POLB: Ordinary SharesDescription
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.96 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 10.25 | |||||
| 9-Day RSI | 15.86 | |||||
| 14-Day RSI | 20.2 | |||||
| 6-1 Month Momentum % | 11.39 | |||||
| 12-1 Month Momentum % | 50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.61 | |||||
| Quick Ratio | 19.61 | |||||
| Cash Ratio | 17.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -30.23 | |||||
| ROA % | -28.86 | |||||
| ROIC % | -163.86 | |||||
| ROCE % | -35.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.46 | |||||
| Price-to-Tangible-Book | 4.33 | |||||
| EV-to-EBIT | -6.47 | |||||
| EV-to-Forward-EBIT | -5.35 | |||||
| EV-to-EBITDA | -6.5 | |||||
| EV-to-Forward-EBITDA | -5.35 | |||||
| EV-to-FCF | -7.27 | |||||
| Price-to-Net-Current-Asset-Value | 4.33 | |||||
| Price-to-Net-Cash | 4.33 | |||||
| Earnings Yield (Greenblatt) % | -15.46 | |||||
| FCF Yield % | -10.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Poolbeg Pharma PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | |||
| EPS (TTM) (£) | -0.009 | ||
| Beta | 2.94 | ||
| Volatility % | 45.96 | ||
| 14-Day RSI | 20.2 | ||
| 14-Day ATR (£) | 0.005099 | ||
| 20-Day SMA (£) | 0.097875 | ||
| 12-1 Month Momentum % | 50 | ||
| 52-Week Range (£) | 0.0638 - 0.15767 | ||
| Shares Outstanding (Mil) | 500 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Poolbeg Pharma PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Poolbeg Pharma PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Poolbeg Pharma PLC Frequently Asked Questions
What is Poolbeg Pharma PLC(LSE:POLB)'s stock price today?
The current price of LSE:POLB is £0.08. The 52 week high of LSE:POLB is £0.16 and 52 week low is £0.06.
When is next earnings date of Poolbeg Pharma PLC(LSE:POLB)?
The next earnings date of Poolbeg Pharma PLC(LSE:POLB) is 2025-04-30 Est..
Does Poolbeg Pharma PLC(LSE:POLB) pay dividends? If so, how much?
Poolbeg Pharma PLC(LSE:POLB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers